FORA Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,093	Closed	-$324K	–	435
2023 Q4	$324K	Sell	9,093 -16,684	-65%	-$594K	0.03%	383
2023 Q3	$767K	Buy	+25,777	New	+$767K	0.07%	278